BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31856089)

  • 21. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways.
    Ock CW; Kim GD
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M; Lu M; Wang Y; Zhao Y; He S; Gao S; Ke Q; Liu Y; Li P; Cui X; Shen A; Cheng C
    Med Oncol; 2009; 26(2):178-85. PubMed ID: 18937079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
    Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting pancreatic cancer cells by a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595.
    Minjie S; Defei H; Zhimin H; Weiding W; Yuhua Z
    Tumour Biol; 2015 Nov; 36(11):9015-22. PubMed ID: 26084607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.
    Zheng YT; Yang HY; Li T; Zhao B; Shao TF; Xiang XQ; Cai WM
    Acta Pharmacol Sin; 2015 May; 36(5):614-26. PubMed ID: 25864651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
    Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC
    Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cells.
    Dasmahapatra G; Patel H; Friedberg J; Quayle SN; Jones SS; Grant S
    Mol Cancer Ther; 2014 Dec; 13(12):2886-97. PubMed ID: 25239935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
    Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
    J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
    Ma J; Guo X; Zhang S; Liu H; Lu J; Dong Z; Liu K; Ming L
    Mol Med Rep; 2015 Jun; 11(6):4525-31. PubMed ID: 25634603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carfilzomib inhibits the growth of lung adenocarcinoma via upregulation of Gadd45a expression.
    Yang F; Liu WW; Chen H; Zhu J; Huang AH; Zhou F; Gan Y; Zhang YH; Ma L
    J Zhejiang Univ Sci B; 2020 Jan.; 21(1):64-76. PubMed ID: 31898443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
    Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
    Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis.
    Hu P; Li H; Yu X; Liu X; Wang X; Qing Y; Wang Z; Wang H; Zhu M; Xu J; Tan R; Guo Q; Hui H
    Free Radic Biol Med; 2019 Dec; 145():237-249. PubMed ID: 31560953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
    Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
    J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.
    Zeng B; Li Y; Niu B; Wang X; Cheng Y; Zhou Z; You T; Liu Y; Wang H; Xu J
    J Mol Neurosci; 2016 Aug; 59(4):567-78. PubMed ID: 27412469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
    Wanek J; Gaisberger M; Beyreis M; Mayr C; Helm K; Primavesi F; Jäger T; Di Fazio P; Jakab M; Wagner A; Neureiter D; Kiesslich T
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.